Earnings Poll: Coloplast fourth quarter results due on November 4
Nov 3 (Reuters) - (All figures in Danish Crowns) Coloplast A/S COLOb.CO reports its fourth quarter results on November 4. Year to date, Coloplast A/S shares are down 25.03%. Below is a table of quarterly and annual analyst estimates for results based on LSEG data.
| Qtr. to September 2025 | No. of analysts | Mean Estimate |
|---|---|---|
| Revenue | 11 | 7.09 billion |
| Pre-tax profit | 6 | 1.79 billion |
| EPS | 9 | 6.25 |
| EBITDA | 6 | 2.17 billion |
| EBIT | 11 | 1.87 billion |
| Net Profit | 10 | 1.31 billion |
| Year to September 2025 | No. of Analysts | Mean Estimate |
|---|---|---|
| Revenue | 19 | 27.99 billion |
| Pre-tax profit | 15 | 6.49 billion |
| EPS | 19 | 21.56 |
| EBITDA | 20 | 8.88 billion |
| EBIT | 19 | 7.5 billion |
| Net Profit | 20 | 4.63 billion |
| Dividend | 20 | 18.88 |
| Net Debt | 13 | 20.55 billion |
Recent news on Coloplast A/S
See all newsMorgan Stanley sees selective medtech opportunities on growth recovery
Brief: Coloplast’s Inflatable Penile Prosthesis Approved By FDA
Denmark's Coloplast Q2 organic revenue rises 6% on urology momentum
Brief: Coloplast Books DKK 3 Bln Impairment In H1
Brief: Coloplast Receives Innovative Technology Contract From Vizient For Biatain® Silicone Fit